Chemours (NYSE: CC) director Courtney Mather granted 7,182 stock units

Rhea-AI Filing Summary

Chemours director Courtney Mather received a grant of 7,182 stock units of Chemours common stock on May 6, 2026. These stock units will convert one-for-one into Chemours common shares upon separation from service on the Board and include deferred and dividend equivalent units. Following this award, Mather holds a total of 21,642.7173 stock units directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MATHER COURTNEY

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,182	$0.00	--

Holdings After Transaction: Common Stock — 21,642.717 shares (Direct, null)

Footnotes (1)

1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. Includes deferred stock units and dividend equivalent units.

Key Figures

Stock units granted: 7,182 stock units Total stock units after grant: 21,642.7173 stock units Grant price per unit: $0.0000 per unit +2 more

5 metrics

Stock units granted 7,182 stock units Grant to director on May 6, 2026

Total stock units after grant 21,642.7173 stock units Holdings following reported transaction

Grant price per unit $0.0000 per unit Equity compensation, no cash paid by director

Transaction code A (Grant, award, or other acquisition) Non-derivative Common Stock entry

Transaction date May 6, 2026 Date stock unit award was recorded

Key Terms

stock units, deferred stock units, dividend equivalent units, separation from service on the Board

4 terms

stock units financial

"Represents stock units that will convert one-for-one to Chemours common stock upon separation"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

deferred stock units financial

"Includes deferred stock units and dividend equivalent units."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

dividend equivalent units financial

"Includes deferred stock units and dividend equivalent units."

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

separation from service on the Board financial

"convert one-for-one to Chemours common stock upon separation from service on the Board."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATHER COURTNEY

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		7,182(1)	A	$0	21,642.7173(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.

2. Includes deferred stock units and dividend equivalent units.

	/s/ Eric Stein, Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Chemours (CC) director Courtney Mather report?

Mather reported receiving a grant of 7,182 Chemours stock units as a board-related award. The units were acquired at no cash cost and are structured as equity compensation rather than an open-market share purchase or sale.

How many Chemours stock units does Courtney Mather hold after this Form 4?

After the reported grant, Mather holds a total of 21,642.7173 Chemours stock units. This total includes the newly granted units as well as previously deferred stock units and associated dividend equivalent units held directly.

When will Courtney Mather’s Chemours stock units convert into common stock?

The stock units are designed to convert one-for-one into Chemours common stock upon Mather’s separation from service on the Board. This means actual Chemours shares are issued only when board service ends, not at the grant date.

What type of insider transaction is shown in this Chemours (CC) Form 4?

The Form 4 shows a grant or award acquisition coded as “A,” not an open-market trade. It represents equity compensation in the form of stock units, rather than Mather buying or selling Chemours shares in the market.

Do Courtney Mather’s Chemours stock units include dividend equivalent units?

Yes, the total stock unit holdings include both deferred stock units and dividend equivalent units. Dividend equivalent units mirror regular dividends by crediting additional units, which will also convert into Chemours common shares upon separation from board service.